Saturday 17 October 2026
Export CERS’s income statement to Excel — free account
Cerus Corporation
CERS Healthcare Medical Devices
In the quarter to June 2026, revenue grew 5.28%, EPS grew 50.3%, free cash flow fell 20.9% and total debt fell 23.5%, each against the same quarter a year earlier.
2.20
0.06
−2.65%
Follow CERS
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Piotroski F-Score |
4 | 4 | 5 | 3 | 5 | 3 | 4 | 4 | 5 | 5 |
P/S ratio |
11.23 | 7.51 | 8.78 | 6.29 | 9.93 | 7.31 | 3.51 | 2.08 | 1.41 | 1.68 |
Altman Z-Score |
(3.92) | (7.17) | (1.55) | (4.12) | 0.35 | (0.54) | (3.24) | (4.87) | (4.94) | (4.00) |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 52.87 | 0.00 | 33.35 | 354.35 |
Altman Z″-Score (non-manufacturers) |
(19.22) | (22.72) | (12.89) | (15.80) | (10.58) | (11.03) | (14.03) | (15.30) | (14.46) | (13.54) |
Beneish M-Score |
(2.82) | (2.44) | (3.05) | (1.34) | (2.66) | (2.51) | (2.52) | (2.22) | (3.35) | (2.87) |
P/Operating CF |
(45.40) | (38.39) | (94.08) | (71.77) | (127.46) | (954.51) | (376.01) | (25.65) | 57.66 | 63.33 |
P/B ratio |
7.63 | 9.89 | 7.90 | 10.34 | 10.93 | 13.62 | 9.63 | 7.29 | 5.00 | 6.04 |
Price to Tangible BV |
7.91 | 10.39 | 8.06 | 10.61 | 11.07 | 13.84 | 9.82 | 7.47 | 5.11 | 6.17 |
EV/Sales |
9.90 | 7.01 | 7.62 | 5.85 | 9.18 | 6.94 | 3.33 | 2.16 | 1.43 | 1.68 |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
(7.26) | (6.89) | (18.56) | (8.38) | (25.09) | (32.62) | (24.51) | (9.34) | 25.35 | 81.38 |
EV/FCF |
(7.18) | (6.84) | (17.90) | (7.37) | (24.16) | (31.77) | 50.28 | (8.44) | 33.79 | 355.26 |
Quick Ratio |
2.92 | 3.16 | 2.40 | 2.04 | 2.58 | 1.97 | 1.17 | 1.50 | 1.73 | 1.12 |
Current Ratio |
3.50 | 3.89 | 2.79 | 2.55 | 3.06 | 2.38 | 1.45 | 2.14 | 2.39 | 1.73 |
Net Debt/EBITDA |
0.88 | 0.55 | 1.64 | 0.65 | 1.55 | 1.31 | 1.04 | (0.51) | (0.30) | (0.14) |
Debt/Assets |
18.72% | 30.33% | 18.27% | 26.84% | 21.73% | 29.23% | 32.01% | 40.35% | 41.89% | 37.81% |
Debt/Equity |
0.34 | 0.77 | 0.35 | 0.78 | 0.46 | 0.81 | 1.02 | 1.49 | 1.48 | 1.29 |
Asset Turnover |
0.32 | 0.51 | 0.58 | 0.57 | 0.59 | 0.70 | 0.83 | 0.90 | 1.01 | 1.11 |
Operating CF/Net income |
0.85 | 0.86 | 0.54 | 0.92 | 0.70 | 0.62 | 0.60 | 1.15 | (0.54) | (0.31) |
Capex/Depreciation |
(0.31) | (0.19) | (0.79) | (3.72) | (0.52) | (0.29) | 12.77 | (1.77) | (1.53) | (2.61) |
Interest Coverage |
(25.13) | (19.04) | (13.72) | (10.92) | (15.57) | (9.94) | (5.84) | (3.58) | (1.60) | (1.04) |
| (82.47%) | (125.27%) | (93.25%) | (100.65%) | (74.42%) | (57.41%) | (55.49%) | (61.45%) | (37.92%) | (25.65%) | |
| (51.80%) | (60.07%) | (43.99%) | (43.31%) | (30.94%) | (23.70%) | (18.78%) | (18.03%) | (10.49%) | (7.39%) | |
ROIC |
(693.97%) | (447.11%) | 0.00% | (262.55%) | (199.05%) | (119.11%) | (58.82%) | (27.87%) | (14.67%) | (8.22%) |
Return on Tangible Assets |
(89.61%) | (87.95%) | (56.24%) | (76.88%) | (43.59%) | (45.03%) | (66.78%) | (43.82%) | (21.89%) | (18.88%) |
Average Days of Receivables |
63.83 | 88.29 | 42.00 | 65.71 | 67.62 | 57.50 | 66.73 | 69.37 | 53.99 | 47.42 |
Research and Development Expense of Revenue |
79.75% | 65.68% | 55.97% | 64.38% | 56.38% | 39.93% | 34.04% | 36.21% | 29.26% | 28.97% |
Selling, General and Administrative Expense of Revenue |
124.65% | 102.51% | 74.74% | 70.60% | 58.66% | 50.96% | 44.25% | 40.43% | 37.70% | 34.61% |
Intangible Assets out of Total Assets |
0.02 | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
Share Based Compensation of Revenue |
20.53% | 18.23% | 13.67% | 14.20% | 15.78% | 14.78% | 12.99% | 10.85% | 11.36% | 9.78% |
Graham Net Nets |
0.11 | 0.08 | 0.10 | 0.03 | 0.06 | 0.03 | 0.03 | 0.00 | 0.03 | 0.04 |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
(14.32%) | (15.73%) | (8.68%) | (12.32%) | (5.20%) | (4.55%) | (6.68%) | (9.58%) | (7.08%) | (3.89%) |
Free Cash Flow Yield |
(12.27%) | (13.65%) | (4.85%) | (12.61%) | (3.83%) | (2.99%) | 1.89% | (12.27%) | 3.00% | 0.28% |
Revenue per Share |
0.39 | 0.47 | 0.58 | 0.67 | 0.70 | 0.93 | 1.07 | 1.04 | 1.09 | 1.23 |
Operating CF per Share |
(0.53) | (0.48) | (0.24) | (0.47) | (0.25) | (0.20) | (0.15) | (0.24) | 0.06 | 0.03 |
Capex per Share |
(0.01) | 0.00 | (0.01) | (0.06) | (0.01) | (0.01) | 0.22 | (0.03) | (0.02) | (0.02) |
Free Cash Flow per Share |
(0.53) | (0.49) | (0.25) | (0.53) | (0.26) | (0.20) | 0.07 | (0.26) | 0.05 | 0.01 |
Cash per Share |
0.70 | 0.56 | 0.89 | 0.61 | 0.81 | 0.76 | 0.58 | 0.37 | 0.44 | 0.43 |
Shareholders Equity per Share |
0.57 | 0.36 | 0.64 | 0.41 | 0.63 | 0.50 | 0.39 | 0.30 | 0.31 | 0.34 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
0.57 | 0.36 | 0.64 | 0.41 | 0.63 | 0.50 | 0.39 | 0.30 | 0.31 | 0.34 |
Free Cash Flow |
(54.09) | (52.59) | (32.39) | (74.43) | (43.43) | (34.83) | 12.49 | (47.76) | 8.52 | 1.11 |
Working Capital |
67.22 | 66.77 | 94.22 | 77.77 | 123.46 | 108.55 | 53.09 | 76.92 | 88.41 | 73.58 |
Capital Expenditures |
(0.56) | (0.35) | (1.14) | (8.93) | (1.61) | (0.91) | 38.10 | (4.60) | (2.84) | (3.73) |
Net Current Asset Value |
48.42 | 30.59 | 67.96 | 19.63 | 65.82 | 35.22 | 20.61 | 0.14 | 8.00 | 17.49 |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.01 | 0.01 | 0.02 | 0.10 | 0.01 | 0.01 | (0.20) | 0.02 | 0.01 | 0.02 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.61 | 0.85 | 0.18 | 0.16 | 0.22 | 0.26 | 0.27 | 0.30 | 0.26 | 0.15 |
Cash ROIC |
(36.35%) | (40.63%) | (13.96%) | (39.76%) | (15.21%) | (12.25%) | 5.19% | (23.99%) | 3.85% | 0.48% |
Accounts Receivable Turnover |
6.20 | 5.32 | 7.19 | 7.32 | 6.01 | 6.89 | 6.32 | 5.34 | 6.17 | 7.77 |
Accounts Payable Turnover |
2.94 | 2.30 | 2.14 | 1.64 | 1.77 | 2.12 | 2.18 | 2.46 | 3.55 | 3.78 |
Inventory Turnover |
1.74 | 1.67 | 2.26 | 2.02 | 1.93 | 2.54 | 2.69 | 2.03 | 2.07 | 1.99 |
Average Days of Payables |
154.43 | 177.78 | 214.55 | 242.30 | 214.73 | 204.76 | 160.71 | 124.38 | 98.07 | 108.93 |
Days of Inventory on Hand |
225.37 | 234.20 | 156.22 | 212.87 | 206.23 | 154.07 | 141.23 | 207.98 | 172.45 | 218.20 |
Average Receivables |
6.33 | 9.64 | 10.58 | 12.82 | 19.02 | 23.15 | 29.78 | 34.96 | 32.64 | 30.08 |
Average Payables |
6.90 | 9.78 | 14.78 | 20.39 | 23.20 | 29.91 | 34.31 | 28.42 | 22.77 | 24.85 |
Average Inventory |
11.67 | 13.49 | 14.00 | 16.51 | 21.37 | 25.02 | 27.90 | 34.44 | 39.01 | 47.13 |
Average Assets |
121.44 | 100.86 | 130.85 | 164.50 | 193.48 | 229.46 | 227.80 | 207.92 | 199.33 | 211.39 |
Average Common Equity |
76.28 | 48.36 | 61.73 | 70.79 | 80.43 | 94.71 | 77.09 | 61.00 | 55.17 | 60.93 |
Columns are period end dates